CY1631A - Pharmaceutical compositions of somatostatin analogues - Google Patents

Pharmaceutical compositions of somatostatin analogues

Info

Publication number
CY1631A
CY1631A CY1631A CY163192A CY1631A CY 1631 A CY1631 A CY 1631A CY 1631 A CY1631 A CY 1631A CY 163192 A CY163192 A CY 163192A CY 1631 A CY1631 A CY 1631A
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
somatostatin analogues
somatostatin
analogues
pharmaceutical
Prior art date
Application number
CY1631A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878716324A external-priority patent/GB8716324D0/en
Priority claimed from GB878716326A external-priority patent/GB8716326D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1631A publication Critical patent/CY1631A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CY1631A 1987-07-10 1992-07-10 Pharmaceutical compositions of somatostatin analogues CY1631A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds
GB878716326A GB8716326D0 (en) 1987-07-10 1987-07-10 Organic compounds

Publications (1)

Publication Number Publication Date
CY1631A true CY1631A (en) 1992-07-10

Family

ID=26292476

Family Applications (2)

Application Number Title Priority Date Filing Date
CY1632A CY1632A (en) 1987-07-10 1992-07-10 Somatostatin analogues for the treatment of breast cancer
CY1631A CY1631A (en) 1987-07-10 1992-07-10 Pharmaceutical compositions of somatostatin analogues

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY1632A CY1632A (en) 1987-07-10 1992-07-10 Somatostatin analogues for the treatment of breast cancer

Country Status (27)

Country Link
US (2) US5753618A (xx)
JP (1) JP2578477B2 (xx)
AU (1) AU618270B2 (xx)
BE (1) BE1001079A4 (xx)
CA (1) CA1328402C (xx)
CH (1) CH677449A5 (xx)
CS (1) CS411591A3 (xx)
CY (2) CY1632A (xx)
DE (2) DE3822557C2 (xx)
DK (2) DK174125B1 (xx)
ES (1) ES2010561A6 (xx)
FI (1) FI93308C (xx)
FR (1) FR2617714B1 (xx)
GB (1) GB2208200B (xx)
GR (1) GR1000172B (xx)
HK (1) HK16492A (xx)
HU (1) HU203480B (xx)
IE (1) IE61908B1 (xx)
IL (1) IL87044A0 (xx)
LU (1) LU87268A1 (xx)
MY (2) MY103746A (xx)
NL (1) NL194823C (xx)
NO (1) NO179359C (xx)
NZ (1) NZ225340A (xx)
PT (1) PT87957B (xx)
SE (2) SE503191C2 (xx)
SG (1) SG3692G (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5626945A (en) * 1993-09-28 1997-05-06 International Paper Company Repulpable, water repellant paperboard
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
WO1998008528A1 (en) * 1996-08-30 1998-03-05 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
ES2167189B1 (es) 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
PT2062914E (pt) * 2001-06-08 2014-07-18 Ipsen Pharma Sas Análogos quiméricos de somatostatina-dopamina
TWI287986B (en) * 2001-12-13 2007-10-11 Novartis Ag Use of Epothilones for the treatment of the carcinoid syndrome
US20030207811A1 (en) * 2002-05-03 2003-11-06 Schrier Bruce K. Method of treating retinopathy of prematurity using somatostatin analogs
PT1787658E (pt) 2005-11-10 2012-06-22 Chemi Spa Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento
JP2009532346A (ja) * 2006-03-31 2009-09-10 イラスマス・ユニバーシティ・メディカル・センター・ロッテルダム 腫瘍増殖制御のための新規組成物
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20090325863A1 (en) * 2008-06-13 2009-12-31 Kleinberg David L Somatostatin analogs and IGF-I inhibition for breast cancer prevention
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
US8629103B2 (en) * 2010-12-02 2014-01-14 New York University Treatment of non-proliferative cystic disease of the breast
CN109248310B (zh) * 2011-06-02 2022-07-01 加利福尼亚大学董事会 利用θ-防御素的炎性蛋白酶的阻断
JP2016503402A (ja) 2012-11-01 2016-02-04 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエＩｐｓｅｎ Ｐｈａｒｍａ Ｓ．Ａ．Ｓ． ソマトスタチン類似体及びそのダイマー
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4374060A (en) * 1981-07-15 1983-02-15 Merck & Co., Inc. Process for the preparation of cyclic hexapeptide
ATE14226T1 (de) * 1981-12-24 1985-07-15 Ciba Geigy Ag Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
US5187150A (en) * 1987-10-14 1993-02-16 Debiopharm S.A. Polyester-based composition for the controlled release of polypeptide medicinal substances
AU2284588A (en) * 1988-09-26 1990-03-29 Sandoz Ltd. Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体

Also Published As

Publication number Publication date
IL87044A0 (en) 1988-12-30
LU87268A1 (fr) 1989-03-08
HU203480B (en) 1991-08-28
NO179359B (no) 1996-06-17
SE8802569L (sv) 1989-01-11
JPS6431728A (en) 1989-02-02
NZ225340A (en) 1991-05-28
DK200100558A (da) 2001-04-04
NO883054L (no) 1989-01-11
CH677449A5 (xx) 1991-05-31
FR2617714A1 (fr) 1989-01-13
SE8802569D0 (sv) 1988-07-08
DK385488A (da) 1989-01-11
FI93308B (fi) 1994-12-15
NO179359C (no) 1996-09-25
SG3692G (en) 1992-03-20
US5753618A (en) 1998-05-19
GR1000172B (el) 1991-11-15
BE1001079A4 (fr) 1989-07-04
NO883054D0 (no) 1988-07-08
IE61908B1 (en) 1994-11-30
DE3822557A1 (de) 1989-01-19
PT87957B (pt) 1995-03-01
DK385488D0 (da) 1988-07-08
HUT47865A (en) 1989-04-28
NL194823C (nl) 2003-04-03
AU618270B2 (en) 1991-12-19
FI93308C (fi) 1995-03-27
IE882091L (en) 1989-01-10
HK16492A (en) 1992-03-06
DK174476B1 (da) 2003-04-14
GB2208200A (en) 1989-03-15
FR2617714B1 (fr) 1991-09-20
FI883261A (fi) 1989-01-11
CA1328402C (en) 1994-04-12
SE9301290A0 (sv) 1993-04-20
JP2764041B2 (ja) 1998-06-11
SE503191C2 (sv) 1996-04-15
JP2578477B2 (ja) 1997-02-05
JPH0748272A (ja) 1995-02-21
FI883261A0 (fi) 1988-07-08
GB2208200B (en) 1991-11-27
DK174125B1 (da) 2002-07-01
MY109309A (en) 1997-01-31
CS411591A3 (en) 1992-06-17
GB8816024D0 (en) 1988-08-10
NL194823B (nl) 2002-12-02
ES2010561A6 (es) 1989-11-16
PT87957A (pt) 1989-06-30
AU1889388A (en) 1989-01-12
DE3845000C2 (de) 1998-11-19
MY103746A (en) 1993-09-30
SE9301290D0 (sv) 1993-04-20
DE3822557C2 (de) 1998-07-02
CY1632A (en) 1992-07-10
GR880100458A (en) 1989-04-12
NL8801734A (nl) 1989-02-01
US6066616A (en) 2000-05-23

Similar Documents

Publication Publication Date Title
GB2208200B (en) Pharmaceutical compositions of somatostatin analogues
GB2196964B (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8608818D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB8713769D0 (en) Compositions of matter
GB2190838B (en) Pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
GB8715966D0 (en) Compositions of matter
GB2188235B (en) Pharmaceutical compositions
AU585890B2 (en) Pharmaceutical use of somatostatin analogues
GB8620073D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
IL75926A0 (en) Somatostatin analogs and pharmaceutical compositions containing them
GB8705183D0 (en) Compositions of matter
GB8703068D0 (en) Compositions of matter
GB8713566D0 (en) Pharmaceutical compositions
IL83572A0 (en) Pharmaceutical compositions comprising a somatostatin analogue
IE862216L (en) Pharmaceutical compositions comprising acylated¹phospholipids
GB8710672D0 (en) Compositions of matter
GB8703069D0 (en) Compositions of matter
GB8707608D0 (en) Compositions of matter
GB8628476D0 (en) Pharmaceutical compositions
GB8616397D0 (en) Pharmaceutical compositions